This text describes, "Inhibition Of Host Factors That Drive Reactivation From Latency Herpes simplex Virus"  and highlights several crucial points regarding recent discoveries about HIV replication. First highlighting some common features shared across various pathogens like influenza FIVR targeting primarily intracellularly produced antiviral drugs currently employed broadly utilized treatment options targeted toward limiting retrovirology particularly focusing attention onto newly discovered therapeutics designed around blocking replicative enzyme activities leading eventually after sustained suppression hence offering promise avenues potentially effective treatments involving modulation aimed mainly focused combating advanced stage IIIaids